The biochemistry of RNA metabolism studied in situ by Nickerson, Jeffrey A.
University of Massachusetts Medical School 
eScholarship@UMMS 
Nickerson Lab Publications Pediatrics 
2009-01-23 
The biochemistry of RNA metabolism studied in situ 
Jeffrey A. Nickerson 
University of Massachusetts Medical School 
Let us know how access to this document benefits you. 
Follow this and additional works at: https://escholarship.umassmed.edu/nickerson 
 Part of the Cell Biology Commons 
Repository Citation 
Nickerson JA. (2009). The biochemistry of RNA metabolism studied in situ. Nickerson Lab Publications. 
https://doi.org/10.4161/rna.6.1.7563. Retrieved from https://escholarship.umassmed.edu/nickerson/2 
This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in Nickerson Lab 




















In vitro assays have contributed important insights into the 
mechanisms of RNA metabolism in cells. A growing collection 
of microscopy techniques is allowing the measurement of macro-
molecular binding and complex formation in the context of a real 
cell. We will first discuss two of the more established techniques. 
Fluorescence resonance energy transfer (FRET) identifies binding 
partners, pairs of molecules residing in the same macromolecular 
complexes. The complimentary technique of fluorescence recovery 
after photobleaching (FRAP) measures the rates of binding and 
unbinding of those molecules in their complexes. A newer tech-
nique—in vitro FRAP—assesses the regulation of binding and 
complex formation by co-factors in the nucleus.
Molecular biology is essentially the practice of biochemistry without a 
license.—Erwin Chargaff
The study of biology took a most productive turn in the 19th 
century with the development of biochemistry, which reduced the 
incredible complexity and diversity of life to a few unifying prin-
ciples of chemistry. Though the experiments of biochemistry have 
uncovered an enormous number of facts about molecules, reactions 
and pathways—it is the principles that have made biochemistry a 
logically consistent body of thought. It is the principles that have 
made it a powerful science.
These principles, indeed most phenomena of life itself, are 
reducible to the processes of binding and catalysis. There is also 
a non-catalytic, spontaneous chemistry in living organisms, but 
binding and catalysis are most central to our understanding of the 
uniqueness of life. All cell structures arise from binding interactions. 
All the macromolecular complexes responsible for creating and using 
RNA, including those responsible for transcription, RNA processing, 
RNA translocation and mRNA translation, are assembled by binding 
and disassembled by unbinding, and in their catalysis they bind 
substrates and unbind products. This catalysis is regulated by the 
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binding and unbinding of regulatory factors, some of which catalyti-
cally modify the complex.
In this article I will concentrate on the binding of macromol-
ecules into complexes and structures, contrasting traditional in 
vitro approaches to an emerging set of techniques that can identify 
binding interactions and characterize the physical biochemistry of 
those interactions by microscopy. Of these many techniques I will 
only briefly examine the use of fluorescence resonance energy transfer 
(FRET) to identify the composition of macromolecular complexes in 
real cells, and the use of photobleaching techniques—including fluo-
rescence recovery after photobleaching (FRAP)—to determine the 
binding constants governing the assembly and disassembly of those 
complexes. Only a few of the many applications of these techniques 
to RNA biology have been selected for discussion. More emphasis 
will be placed on “in vitro FRAP,” an extension of the FRAP method, 
which permits the identification of small molecules that regulate 
macromolecular complex assembly and the characterization of the 
mechanisms by which they do so.
These powerful, though often difficult, techniques allow the 
biochemical characterization of molecular interaction in cells, rather 
than in tubes. They overcome the major limitation on biochemistry 
in the past, and will help us refute the damning critique of Erwin 
Chargaff that, “…biochemistry is helpless before life, having to kill 
the organism before investigating it. Biochemistry is, in fact, much 
more successful in practicing the second part of its composite name 
than in following the prefix.”
The Power of Biochemistry: Mechanism and Manipulation
In vitro biochemistry offers great power for the characterization of 
molecular interactions and reactions, because systems can be simpli-
fied to their essential components. Sometimes systems can even be 
reconstituted from isolated components, leaving no doubt that the 
system is self-contained. Even when this is not possible, individual 
components can be depleted and added back, with the consequences 
noted. This power of in vitro biochemistry comes with the significant 
and paradoxical costs of oversimplification and overcomplication. 
In vitro systems ignore components present in cells, but lost by the 
isolation protocols used to reconstitute simplified systems. On the 
other hand, in vitro systems may identify and characterize molecular 
interactions that might not function in cells. For example, two 
proteins may interact when they encounter, but may normally be in 
different cellular compartments. At least, until homogenization.
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UAP56 is an ATP-dependent RNA helicase of the DExD/H box 
family with, in various species, a role in RNA splicing and in 
mRNA export to the cytoplasm. In our studies, a point mutation 
that blocked ATP binding to UAP56, and had a dominant negative 
effect on mRNA export, also abolished FRET with SRm160 at RNA 
splicing speckled domains.6
This was not the first application of FRET to the study of RNA 
metabolism. One interesting, earlier use of FRET probed the role 
that Cajal Bodies in the nucleus play in the assembly of the U4/
U6·U5 tri-snRNP complex.7 The results were consistent with a 
mechanism in which some U4 snRNP and U6 snRNP complex 
assembly occurs in the nucleoplasm before these complexes move 
from the nucleoplasm into Cajal Bodies for the next step, U4/U6 
snRNP assembly. Further FRET studies established a physical inter-
action between the Cajal Body protein coilin and the snRNP protein 
SMN and this interaction was localized to Cajal Bodies.8
FRET can be performed in live cells or after fixation. A common 
use of FRET is with fluorescent fusion proteins, but FRET between 
fluorescently tagged nucleic acids and proteins is also done. For fixed 
cells, fluorescently tagged antibodies can also be used. For example, 
molecular beacon-based FRET between snRNA and anti-fibrillarin 
antibodies (FITC) confirmed the interaction between fibrillarin 
and snRNA, identifying subnuclear sites of interaction in nuclei of 
Giardia lamblia.9
Newer methods of in vitro biochemical 
analysis can yield too much information, 
cluttering and obscuring our understanding 
of mechanism. For example, co-immuno-
precipation combined with protein mass 
spectrometry can identify hundreds of 
potential binding partners. Not all binding 
interactions are equal in prevalence or 
importance in living cells; not all exist in 
cells. The inclusion of low-significance 
interactions on a protein mass spec-
trometry list can confound, rather than 
clarify, our thinking about biological func-
tion. SRm160 is an important mRNA 
splicing factor,1 later found in mRNA 
export complexes. A proteomic study of its 
binding partners, identified 110 co-immu-
noprecipitating proteins.2 Theoretically, by 
including only a single copy of SRm160 
and of each partner in complexes we could 
assemble 110 different dimers, 12,100 
different trimers, more than 1.3 million 
tetramers, and so on. It is important to 
supplement these powerful techniques of 
in vitro biochemistry with experimental 
approaches that detect the complexes that 
actually form in cells and at the locations 
where they exist.
Determination of Molecular 
Interaction in Cells
FRET is also known as Förster resonance 
energy transfer in honor of Theodor Förster, who first recognized 
the principle and developed the theory.3 After a fluorochrome in 
solution absorbs light, vibrational relaxation occurs rapidly. If there is 
a resonance of the energy transitions between the fluorochrome and 
a nearby, unexcited fluorochrome, there can be a transfer of energy 
and emission of light from the second fluorochrome. The emitted 
light from the second fluorochrome is at a higher wavelength than 
the fluoresced light from the first, and so is spectrally distinguishable. 
The application of this phenomenon to microscopy is presented in 
the cartoon of Figure 1.
In practice, FRET between two flourophores occurs only when 
the distance between them is in the range of 1–10 nM.4 At this 
distance we can be assured that both proteins are present within the 
same complex. In fact, because FRET efficiency decreases with the 
6th power of the distance between two fluorophores, FRET might 
theoretically be used as a distance measurement. This would be 
difficult to achieve in practical cell biology. Nevertheless, the deter-
mination that two fluorochromes are present in the same 10 nm or 
smaller area, lets this technique evade the law of physics that would 
practically limit the spatial resolution of light microscopy to about 
200 nm.5
In the case of SRm160, with its 110 potentially interacting 
proteins, we have recently used FRET to show that mRFP-SRm160 
interacts with GFP-UAP56 at RNA splicing speckled domains.6 
Figure 1. FRET measures macromolecular interactions. In this drawing of a typical FRET experiment, the 
puzzle pieces represent proteins fused to GFP and mRFP that can bind together in complexes. When 
they are not incorporated into the complex, only GFP is excited by light at 488 nm and only GFP emits 
fluoresced light. When both proteins are present in the same complex and their fluorescent domains are 
close together, GFP is excited at 488 nm but transfers some of the energy of excitation by a non-radiative 
process to the nearby mRFP. The mRFP, now excited by the transfer, can fluoresce light with an energy 
distribution of its own higher wavelength emission spectrum. The equation at the bottom shows that FRET 
efficiency falls off with the 6th power of the distance between the fluorescent domains, so that both must 
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Recently, FRET has been combined with FLIM to localize sites 
in cells where mRNA splicing complexes form.11 The interacting 
proteins were the SR proteins SC35 and ASF/SF2, HCC1/CAPER, 
a 70K U1snRNP associated protein bound near the 5' splice site of 
the pre-mRNA, and the U2 snRNP-auxiliary factors U2AF35 and 
U2AF65 bound at the 3 splice site. Protein-protein interactions, first 
identified by in vitro assays as significant in splice site definition, were 
found to actually occur in cells at sites within the nucleoplasm and 
at RNA splicing speckled domains. In addition, interactions between 
HCC1/CAPER and both U2AF35 and U2AF65 were identified that 
had not been previously reported, consistent with a role for HCC1 
in 3' splice site selection. FLIM may provide a more sensitive and 
higher contrast measure of FRET—fluorescence lifetime decreases 
with FRET—and FLIM can provide more information about the 
heterogeneity of complexes in a single voxel.12
Binding Rate Constants Determined in Cells
While FRET can identify the molecules binding in complexes, the 
physical chemistry of binding, including the measurement of kinetic 
parameters, of equilibrium constants, and of the sizes of bound versus 
diffusing pools is readily studied in live cells by the complimentary 
technique of FRAP (Fig. 2), and its many derivatives.
In FRAP, a fluorescent molecule is introduced into a cell. A fluo-
rescent spot or region of interest in the cell is photobleached. The 
rate of fluorescence recovery is measured. If there is recovery, then the 
photobleached or “dark” molecules in the bleach zone are replaced 
by homologous fluorescent molecules from other regions of the 
cell. When the fluorescent molecule is bound in a relatively immo-
bile complex, the mechanism for this replacement must include 
unbinding of the “dark” molecules in the bleach zone, the unbinding 
of still fluorescent molecules outside of the bleach zone, the exchange 
of these two pools of molecules by diffusion, and the binding of fluo-
rescent molecules to complexes in the bleach zone.13 Thus the rate of 
recovery depends on binding and unbinding constants, and on diffu-
sion coefficients.13 If, as is usually the case in living cells, binding or 
unbinding are rate limiting then these binding constants, but not the 
diffusion coefficient, can be calculated from FRAP results.14,15
The first FRAP studies were designed to measure the lateral 
mobility of membrane proteins and test the fluid mosaic model 
of membrane structure.16,17 The theory for analyzing these experi-
ments accounted only for diffusion. The FRAP experimental design 
was later adapted to three dimensional molecule mobility and laser 
scanning confocal microscopy.18 The broadening of FRAP theory to 
include binding of fluorescent molecules to intracellular structures 
then allowed the measurement of binding constants.13-15,19-22
The first uses of FRAP to study the dynamic function of nuclear 
proteins important in RNA metabolism were by the Misteli and 
Hendzell laboratories. The results showed, for example, that the 
photobleach recovery of the GFP-ASF/SF2 splicing factor was two 
orders of magnitude slower that that of just GFP.23,24 Photobleach 
recovery can be retarded by making the recovering molecule large, 
perhaps, as part of a tightly bound complex. However, as the diffu-
sion coefficient is inversely proportional only to the cube root of 
the mass,25 such a complex would need to be unreasonably large in 
order to account for such a large difference in recovery time between 
GFP-ASF/SF2 and GFP. It is more likely that the recovery is slowed by 
binding. The bleached molecules must be released from their binding 
FRET/FLIM
There are many microscopic protocols for measuring FRET,10 
all with substantial practical difficulties. Techniques for measuring 
FRET rely on fluorescence intensity measurements, but fluorescence 
intensity can be altered by other phenomena, and its measurement 
in FRET experiments is complicated by spectral overlap. More 
fundamentally, FRET can be difficult to establish as it depends 
on the distance between, orientation, and environment of the two 
molecules. As a result, a negative result cannot be interpreted as a 
lack of interaction and this, more than the technical issues, can make 
FRET a frustrating technique.
These difficulties in performing FRET studies have encouraged 
the search for alternative methods of FRET measurement. One 
promising approach detects FRET by the alteration of fluorescence 
excitation lifetime of the fluorochrome using fluorescence lifetime 
imaging microscopy (FLIM). Originally a spectroscopic technique, 
fluorescence lifetime measurements have been adapted to many 
microscopy systems. Fluorescence lifetime is very sensitive to changes 
in the microenvironment around a fluorochrome. For a GFP fusion 
protein, a very effective way to change that environment and to 
decrease fluorescence lifetime is to move a big FRETing fusion 
protein, for example one with mRFP, into the neighborhood. A big 
advantage of FLIM for detecting FRET is that it is a time measure-
ment and not an intensity measurement.
Figure 2. FRAP measures binding kinetics. This typical FRAP scheme mea-
sures the binding of a fluorescent mRNA splicing factor in complexes at 
RNA splicing speckled domains. The live cell is imaged to measure the pre-
bleach distribution of the fluorescent protein. One speckle, or alternatively 
a region of the nucleus containing that speckle, is photobleached with high 
intensity laser light. A sequence of images is collected at time intervals after 
the bleach. In order for the fluorescence to recover in the bleached speck-
led domain, photobleached molecules must unbind from their complexes 
and still fluorescent molecules in unbleached speckled domains must also 
unbind. The two pools of splicing protein, fluorescent and dark, equilibrate 
by diffusion. Fluorescent molecules, diffusing into the bleach zone must then 
bind. For most proteins, this experiment is measuring binding or unbinding 
rates.13 The fluorescence measurements after photobleaching are corrected 
for the fractional loss of fluorescence in the nucleus caused by the bleach. 
Data is often reported as a halftime (t1/2) of recovery. For many nuclear 
proteins it is observed that there are at least two populations: a population 
of photobleached molecules that are replaced, and an “immobile fraction” of 
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photobleached without and with the chosen small molecule and the 
recovery time courses can be compared. And then the cofactor can be 
added back and the photobleach recovery again measured.
The requirements of this technique are that the fluorescent mole-
cule must be resident in the nucleus, must be too large to passively 
diffuse through nuclear pores, that the small cofactor molecule 
must be small enough to pass through pores, and that the binding 
site being photobleached must be relatively immobile over the time 
course of recovery. In control experiments, it is important to verify 
that the nuclear envelope remains impermeable to macromolecules 
after digitonin extraction. This can be measured by incubation with 
antibodies against nuclear proteins.29 An extended in vitro FRAP 
protocol with partial solubilization of the nuclear envelope has been 
reported30 and used to characterize the role of molecular chaperones 
in the nuclear mobility of steroid receptors.
We developed in vitro FRAP to address a paradox in the behavior 
of the mRNA splicing and export factor SRm160,28 which, as we 
have discussed above, has 110 potential binding partners. We showed 
by FRET that some of these complexes in cells also contain UAP56.6 
Live cell FRAP studies revealed that the was a rapid exchange of 
GFP-SRm160 at RNA splicing speckled domains. However, when 
the cell was permeabilized the exchange stopped and the protein was 
stably bound for periods of up to an hour. It seemed possible that 
sites at speckled domains, fluorescent molecules bound outside of the 
bleach zone must also unbind. The two pools must equilibrate while 
fluorescent molecules bind at sites vacated by bleached ones. The 
recovery kinetics of ASF/SF2, similar to those of most RNA splicing 
factors studied since, are consistent with binding and not diffusion 
being rate limiting. A back of the envelope estimate suggests that a 
molecule like ASF/SF2, recovering two orders of magnitude slower 
than would be expected for a diffusion-limited recovery, may be 
diffusing only 1% of the time and the rest of the time is bound. More 
sophisticated tools for determining whether diffusion, unbinding, or 
binding are rate limiting have been presented, as have more sophis-
ticated tools for measuring binding residence.13-15 An additional 
factor that can slow photobleach recovery is the tortuosity of the 
nucleus, but this has not yet been adequately measured.
A powerful application of FRAP to the study of transcriptional 
control has used tandem arrays of model genes, all integrated into 
chromosomes. The integrated arrays provide a large target for photo-
bleaching fluorescent transcription factors. Such studies have shown 
a surprisingly high rate of transcription factor turnover on promoters 
(reviewed in refs. 26 and 27). Many related alternative protocols 
to FRAP have been presented, using photobleaching or using laser 
activation of fluorochromes, and all with advantages for some experi-
ments. We will concentrate below on only one extension of FRAP 
that allows for biochemical manipulation.
The assumptions on which a FRAP experiment are built frequently 
include the thought that tacking a large GFP on one end of a protein 
molecule will not affect its binding or function. Since almost all 
FRAP experiments are overexpression experiments, it must also be 
assumed that this overexpression has not overwhelmed the number 
of available binding sites. We have tried to address this potential 
problem by using stable cell lines where possible, in the hope that the 
level of overexpression is at least not toxic, and by comparing FRAP 
data from cells with different expression levels in the same experi-
ment.28 While these underlying assumptions cannot be completely 
correct, it is remarkable that FRAP experiments have generally 
yielded internally consistent results that are also consistent with in 
vitro data.
In vitro FRAP
We developed a novel FRAP technique that assesses the role that 
small molecules play in the binding and exchange of macromol-
ecules in nuclear complexes.28 This technique—in vitro FRAP—is 
presented schematically in Figure 3. A fluorescent molecule, for 
example a fluorescent-fusion protein, is introduced into a cell, where 
it binds in a complex at a structure in the nucleus. The structure, 
or a region of the nucleus, is photobleached and the time course of 
recovery is measured, providing information about the binding and 
unbinding of the fluorescent molecule in a live cell. Cells are then 
extracted in 50 mg/ml digitonin to permeabilize the cell membrane 
without removing the nuclear envelope, a preparation protocol 
originally developed to characterize nucleocytoplasmic trans-
port.29 Molecules smaller than the diffusion limit for nuclear pores 
(40 to 60 kDa), for example Mg2+ATP, can be depleted from nuclei 
or added back to the nucleoplasm while larger molecules, including 
fluorescent fusion-proteins, are constrained within the nuclear 
volume. In the case of ATP, nuclear levels decline to 1 nM or less 
in of digitonin-treated cells. The fluorescent molecule can then be 
Figure 3. In Vitro FRAP identifies cofactors required for binding or unbind-
ing. This extension of the FRAP assay measures the effect that cofactors 
have on the binding of fluorescent nuclear proteins. In the example shown, 
a fluorescent fusion protein is concentrated in the RNA splicing speckled 
domains of a live cell. The cell is extracted in digitonin which permeabilizes 
the cell membrane but leaves the nuclear envelope intact as a barrier to 
the diffusion of large molecules. Molecules smaller than 40 to 60 kDa are 
rapidly depleted from the nuclear interior by diffusion. The effect of this 
depletion on binding and unbinding can be measured by photobleaching 
before and after digitonin permeabilization. Small molecules can be added 
back through nuclear pores, and the kinetics of photobleach recovery again 
measured. If fluorescence recovery is restored, then the supplemented factor 
may be a co-factor necessary for the binding of the fluorescent protein into 
complexes at speckled domains. In the first application of this technique 
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factor responsible for mediating the ATP dependence of exchange 
was unlikely to be a protein kinase. As we could find no evidence 
that SRm160 itself had an ATP binding site, this result suggested 
ATP-dependent RNA helicases as candidates. Several DExD/H 
box helicases, including UAP56 are present in splicing and export 
complexes with SRm160, and there is evidence that some members 
of this family of helicases can remodel RNA-protein structures before 
ATP hydrolysis.
In vitro FRAP experiments showed that ATP was also required 
for the binding of UAP56 into complexes at RNA splicing speckled 
domains (Fig. 5). This ATP-dependence was lost when a point 
mutation blocking the binding of ATP was made.6 This same muta-
tion in UAP56 had a dominant negative effect on the export to the 
cytoplasm of spliced RNA reporter constructs.6 However, expres-
sion of the dominant negative UAP56 did not influence the rate 
of GFP-SRm160 photobleach recovery in live cells or change the 
ATP-dependence of GFP-SRm160 recovery in the in vitro FRAP 
assay. This suggests that UAP56 is not the ATP-binding factor that 
mediates the ATP-dependent release of SRm160 from complexes at 
RNA splicing speckled domains.
a co-factor mediating exchange was lost when the nuclear envelope 
was extracted.
One possible cofactor was ATP. We first tried reducing ATP levels 
by treating cells with 10 mM sodium azide plus 6 mM 2-deoxyglu-
cose in the absence of glucose for 15 to 30 minutes. This resulted 
in a small but significant slowing of photobleach recovery in treated 
cells. When we measured the resulting cellular ATP levels, they were 
reduced, but ATP concentrations were still higher than the expected 
Km for ATP of a typical kinase.28 There might still have been suffi-
cient ATP persisting to maintain an ATP-dependent EGFP-SRm160 
exchange.
Depletion of ATP from nuclei by digitonin permeabilization 
rapidly removed ATP from the nucleus and stopped the exchange 
of EGFP-SRm160 at speckled domains; there was no recovery of 
fluorescence after photobleach. The rate at which control proteins, 
including GFP-hnRNPA2, recovered after photobleaching was 
unchanged. Adding back 1–5 mM ATPMg2+ restored the recovery 
of GFP-SRm160 after photobleaching. We concluded that the 
unbinding of SRm160 from complexes at speckled domains required 
ATP.28
One of the advantages of in vitro FRAP is that it studies complex 
assembly in real nuclei, but it offers a capacity for biochemical 
definition and manipulation that is more characteristic of an in vitro 
system. For example, the nucleotide specificity of SRm160 unbinding 
from complexes at speckled domains could be studied (Fig. 4). 
The big surprise from those experiments was that non-hydrolyzable 
analogues of ATP fully restored the exchange of SRm160. Thus, the 
Figure 4. In vitro FRAP reveals the nucleotide specificity of GFP-SRm160 
exchange in complexes at RNA splicing speckled domains. HeLa cells stably 
expressing GFP-SRm160 were permeabilized with digitonin. Before photo-
bleaching, either buffer alone, 5 mM ADP, 5 mM ATP, 5 mM GTP, 5 mM 
AMP-PNP or a combination of ATP and GTP (5 mM each) were added. Each 
point represents the mean for the number of photobleached cells indicated 
to the right of the curve. This figure is adapted from Wagner et al. 2004 in 
the Journal of Cell Biology.28
Figure 5. In vitro FRAP shows that the binding of GFP-UAP56, but not its K95N 
mutant, at RNA splicing speckled domains is ATP dependent. HeLa cells were 
expressing GFP-UAP56 wt or the GFP-UAP56 K95N point mutant that cannot 
bind ATP. After 24 hours, a nuclear region of interest was photobleached. 
The fluorescence recovery of EGFP-UAP56 or its K95N mutant at a speckled 
domain was recorded. In live cells, the fluorescence of both proteins recov-
ered after photobleaching showing that UAP56 was exchanging on binding 
sites at speckled domains. After digitonin permeablization, the FRAP recovery 
of EGFP-UAP56 stopped. Addition of 1 mM ATP restored FRAP recovery 
to EGFP-UAP56, showing that the FRAP mobility, that is the exchange at 
speckled domain binding sites, is ATP dependent. In contrast, after digitonin 
permeabilization GFP-UAP56 K95N recovered after photobleaching show-
ing that its exchange at speckled domains was ATP independent. Shown 
are the calculated recovery curves with the number of cells noted on each 
graph. Means are plotted with error bars for standard deviations. This figure 
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The in vitro FRAP assay provides a tool for evaluating the effect 
that co-factor molecules may have on the binding of larger proteins 
into nuclear complexes, and for evaluating this in the context of an 
intact nucleus. Co-factors suitable for this assay need only be smaller 
than the diffusion limit of nuclear pores, so even small proteins and 
individual protein domains might be used. The assay can also be 
combined with pre-treatments of the live cell that include drugs, 
the knockdown of partner proteins, and expression of mutant forms 
of either the fluorescent protein or of its putative binding partners. 
The combination of the in vitro FRAP assay with high throughput 
microscopy systems may even allow this assay to be used as a tool for 
drug discovery, evaluating candidate compounds small enough for 
passive diffusion into the nucleus.
Conclusion
We have witnessed an explosion of new microscopy technologies 
in recent years and are only beginning to exploit them. It is likely that 
the current progress in microscope development and application will 
accelerate. These technological advances have facilitated a growing 
repertoire of techniques that allow an in situ analysis of the biochem-
istry of living systems. The key advantages of these approaches are 
that the cellular context is preserved, providing spatial and architec-
tural information, and that the molecular interactions studied are 
biologically relevant. The major disadvantages are that the techniques 
can be experimentally slow and difficult, and they require expensive 
instrumentation. For example, establishing a protein-protein interac-
tion by co-immunoprecipitation is generally much faster, easier and 
cheaper than showing that this interaction is biologically relevant by 
FRET.
Advances in microscopy may change the very way in which we 
think about biology. As the resolution of physics improved with 
quantum mechanics, the universe was revealed to be more jiggly 
and stochastic, and less determinant than had been imagined. An 
improvement in the spatial and temporal resolution of microscopy 
may reveal similar properties underlying biology.
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